Apr 8, 2025 8:00am EDT SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Mar 12, 2025 5:08pm EDT SCYNEXIS Reports Full Year 2024 Financial ResultsĀ and Provides Corporate Update